chrisvoncsefalvay/vaers-outcomes huggingface dataset:
less taste; could not taste anything; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (less taste) and TASTE DISORDER (could not taste anything) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 025A21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for Cholesterol, ATENOLOL and OLMESARTAN MEDOXOMIL for Hypertension, HYDROCHLOROTHIAZIDE for Hypertensive, SOLIFENACIN SUCCINATE for Overactive bladder, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced AGEUSIA (less taste) and TASTE DISORDER (could not taste anything). On 06-May-2021, AGEUSIA (less taste) and TASTE DISORDER (could not taste anything) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Received rotavirus vaccine 8/22.  On 8/31 had stool with specks of blood but otherwise well.  Seen on 9/1/06 diagnosed with presumptive milk protein allergy.  Mom taken off dairy and say (patient breast feeding only).  Blood resolved after few days. Seen over 9/30/06 - blood in stool resolved.
Day after vaccine administration, sleeping more than usual, denied fever, occasional vomiting, normal BM & wet diapers, not feeding as well as usual. 12/17/12 doing better today.
Information has been received from a physician concerning a patient who was vaccinated with a dose of Gardasil. A week later the patient experienced swelling of the wrist, ankles and feet with edema and extreme sensitivity. The patient was seen in the ER and was given NAPROSYN. The patient's outcome was unknown. No product quality complaint was involved. Additional information is not expected.
I stood up after first vaccine and became dizzy, tremendous headache.  I had dull headaches after 1st vaccination x 1 month into the 2nd vaccine which continued 2 more weeks. After 2nd Vaccine had flu like symptoms x 24 hours, weak, never did gain my strength back completely. then required hospitalization 12/2001 with pneumonia in both lungs. I am not a smoker or have any Comorbidities.
Approximately 6 hours after the vaccination, I developed chills, high fever (4+ degrees above normal), extreme fatigue, headache, sore arm, stuffiness. This lasted 48 hours. I did not take any medications until 34 hours after vaccination, I took 2 tylenol to help me sleep
Information has been received from a registered nurse concerning a 16 year old female who on approximately 10-SEP-2007 was vaccinated with the first dose of GARDASIL IM. The patient passed out in the elevator when she left the office. The patient's fainting lasted for 15-30 seconds. She was brought back to the office and went home after recovery that same day. No further information is available.
26 y/old female received influenza vaccine injection on 10/5/2010. Patient reported that hours (specific hour not specified) post-vaccination she developed general discomfort (myalgia, fatigue). 1 day post vaccination, patient developed hives and vision problems. These symptoms still persisted on 10/7/2010. Patient did not seek medical treatment. This is the only information available, as the patient did not agree to be contacted by us.
Information has been received from a nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 28-NOV-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot # M013636, expiration date 15-FEB-2018 (strength, dose, administration route and anatomical location were not provided) for prophylaxis. No adverse effects were reported. The vaccine had two temperature excursions one of 29.9 Fahrenheit (F) for 2 hours 30 minutes and the other of 47.7 (F) for 30 minutes; with a data logger involved. Also it was reported no previously excursions. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1612USA000346: US-009507513-1612USA000348: US-009507513-1612USA000349: US-009507513-1612USA000350: US-009507513-1612USA000351: US-009507513-1611USA013515.
Three days after my vaccination I started having ringing in both ears. I do not remember the exact time I noticed it but I did mention it to my husband the evening of 04/05/2021. We had saw something on the news about Tinnitus so I did contact my doctor. I am not sure when I had the tele-visit with my PCP but my doctor sent me to an ENT specialist. They did a hearing test and concluded I could hear. The Tinnitus was not interfering with my ability to hear but was annoying. I feel the emphasis was more concern about getting vaccinations than possible issues with ringing in the ears. The ENT and they performed standard hearing and pressure tests. I was told all normal and hearing was very good and they treated it more like it was Tinnitus. For whatever reason, in November I had completely lost hearing in my right ear.  They put me on a steroids and diagnosed a  Sudden Hearing Loss event. I was referred back  to the ENT. I went same day and was diagnosed with Profound Hearing loss of the right ear. They ordered a CT Scan and they administered four steroid injections in the right ear as well as oral steroid. After the steroids and recommended treatments which was oral steroids and the series of four shots my hearing did not come back. I was just told there is nothing more they could do for me. I am now completely deaf in my right  ear which the diagnosis again of Profound Sudden Hearing Loss. Presently I have not regained hearing in my right ear and I was told I could try Cross-link device.
Itchy heat rash type bumpy rash over chest, neck, upper arms, forehead showed up 5 days post injection
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. The pharmacist reported that, on 22-SEP-2014, the patient received expired ZOSTAVAX (lot # J006832; expiration date 14-SEP-2014; dose and route not provided). The pharmacist stated the ZOSTAVAX did not have any previous temperature excursions. The ZOSTAVAX was found to be supported with in-house stability data. No adverse symptoms reported. Additional information has been requested.
Patient reported dizziness with vision loss (partial and temporary).  Patient reported to be Brady for 4-5 minutes. HR increased. Patient went to bathroom and c/o cramping, diaphoresis noted but symptoms resolved.
Event described to me by RN who administered the vaccine, the patient was nervous prior to receiving vaccine and experiences anxiety regularly. After receiving vaccine, patient became increasingly anxious and began sweating. Blood pressure reportedly dropped to 90/70 at which time RN administered an epipen 0.3mg. 911 was subsequently called to further care for the patient.
Small lump formed at injection site and never went away. Patient asked doctor in January and was told to monitor it. Patient came into pharmacy on 3/6/19 and told the pharmacist about the lump.
Couple days after vaccination, the area where vac administered was itch and it last a week or so. After about a week itch sensation is gone but the skin was irritated and rough.  And at the same time, (as soon as after vaccination, left arm and left shoulder is hurt, muscle pain,  and the pain is persistent until now. It has been almost 3 weeks since vaccination, the pain is won't go away.
pt recvd vax & 30 days p/vax pt was found to have a positive hepatitis B surface antigen;outcome:sx persist
I became increasingly sick within 24 hours after the shot. I was very tired, felt feverish, very cold, coughing, headache and diarrhea.  36 hours after the shot I began to notice a loss of taste and smell. 48 hours I was very weak and needed to sleep for the next 3 days.  Overall loss of appetite, diarrhea and very bad cough continued for at least 1 week.
had the vaccination / got shingles about a year later/suspected vaccination failure; got shingles about a year later; very painful!; This case was reported by a consumer via media and described the occurrence of Suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient itself. The age at vaccination was not reported. The patient got Shingles about a year after vaccination, which was very painful. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting.
Tremors for 4 days; Very swollen neck glands; Headache 3 days; Weakness 2 weeks; Heart palpitations on going; Stomach problems ongoing; Dizziness 2 weeks; Overall unwell feelings ongoing; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation (afib) and sulfa allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included diltiazem hydrochloride (CARTIA XT) for unknown indication on unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 06Apr2021 at 00:00, the patient experienced tremors for 4 days; very swollen neck glands; headache for 3 days, weakness for 2 weeks, heart palpitations on going, stomach problems ongoing, dizziness for 2 weeks and overall unwell feelings ongoing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache for 3 days was resolved on 03Apr2021 and tremors for 4 days was resolved on 10Apr2021. The clinical outcome of the events weakness for 2 weeks and dizziness for 2 weeks was resolved on an unknown date in Apr2021. The clinical outcome of the event very swollen neck glands was resolving, while that of heart palpitations on going, stomach problems ongoing and overall unwell feelings ongoing was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Diffuse erythematous pruritic rash primarily lower extremities and back, wax and wanes.  Started on 2/21 and has persisted until seen today in clinic on 3/3/2021.
PROQUAD and VARICELLA were administered at the same time instead of MMR and VARICELLA separately.
HPV vaccine #2 was given upper R deltoid 4 days ago. Arm was hurting that evening, seemed to be hurting more than usual with a vaccine. Developed swelling and pain in right armpit next day. Day before yesterday mom looked at it and it looked terrible, swollen and red all in her armpit. Family was away for a soccer tournament, decided to wait. Has gotten a little better, still a little swollen, still hurting.  Otherwise feeling fine. Normal energy, normal appetite. Played soccer this weekend. No fever. No vomiting or diarrhea. Sleeping fine at night.
BODY ACHES; SWEATS; CHILLS; FEVER; HEADACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, sweats, chills, fever, and headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, sweats, chills, fever, and headaches. This report was non-serious.
BLANCHING RED RASH ALL OVER HER BODY, w/ Cough, runny eyes, runny nose, fever, malaise, discomfort, crying, spots in mouth, treating currently at home and still observing symptoms and treatment. Symptoms have continued over a course of less than a week. Symptoms Presenting like classic Measles.
The pt experienced urticaria on his face with edema of upper eyelids bilaterally and one hive on right leg. There was not airway compromise or breathing difficulty. Pt was given one dose of Benadryl and observed in the office.
pt recv vax; localized erythema w/ tenderness on ctr area involving about 15 cm obsicular shape around arm;
This case was reported by a pharmacist via call center representative and described the occurrence of encephalopathy in a 63-year-old male patient who received SHINGRIX for prophylaxis. On 25th September 2018, the patient received the 2nd dose of SHINGRIX. On 28th September 2018, 3 days after receiving SHINGRIX, the patient experienced encephalopathy (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the encephalopathy was recovered/resolved. It was unknown if the reporter considered the encephalopathy to be related to SHINGRIX. Additional details were provided as follows: The pharmacist reported that the patient was admitted to the hospital on 28th September 2018 and diagnosed with encephalopathy. The patient's cerebrospinal fluid cultures were all negative and everything from a micro standpoint was negative as well. The reporter had provided contact details of the physician. Lab Comments: The patient's CFS cultures were all negative and everything from a micro standpoint was negative as well.
The patient did not report any adverse event so far; they accidentally gave a dose of MMR instramusculary as opposed to subcutaneously; This spontaneous report was received from a pharmacist referring to a 40-year-old female patient. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not provided.  On 21-JUL-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, at a dose of 0.5 milliliters (ml) (lot #U006488 with an expiration date on 26-FEB-2023), administered intramuscularly for prophylaxis (strength was not provided).  On 21-JUL-2022, approximately 30 minutes prior to the reporting time, accidentally was administered a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) intramuscularly as opposed to subcutaneously (incorrect route of product administration). The injection was given in the patient's right arm. The patient did not report any adverse events so far.
3 weeks since my second dose and I still feel sick; losing weight; body ache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (3 weeks since my second dose and I still feel sick), WEIGHT DECREASED (losing weight) and MYALGIA (body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (3 weeks since my second dose and I still feel sick), WEIGHT DECREASED (losing weight) and MYALGIA (body ache). At the time of the report, ILLNESS (3 weeks since my second dose and I still feel sick), WEIGHT DECREASED (losing weight) and MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  No treatment information was reported.   Reporter did not allow further contact
Started 2-6-2021 @ approx 4am. Slight body aches, headache and chills. Throughout the day the symptoms increased to moderate and temperature was 100.5 and increased to 102. Took Tylenol at 7:30 pm. Arm extremely sore with redness surrounding injection site between size of golf ball and orange.  Vsafe did not send me a link until after 9pm at night, was sleeping. Link expired at 11:59 pm. Never got a chance to report
Injection site redness, swelling, hot. Area has gotten larger each day.. Vaccination was 13 days ago.
pain; itching; Initial information received on 15-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves patient (unknown demographics) who experienced pain and itching (pruritus), while he/she received vaccine INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  Medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious pain and itching (pruritus) (unknown latency) following the administration of INFLUENZA VACCINE.  It was also reported that product name was not provided. Since this is a public post on the Sanofi flu shot campaign The Race for 200M we are assuming the consumer is referring to the Sanofi flu vaccine. Author/Reporter Comment: patient took the flu shot, arm felt as were bitten by something pain and itching applied ice and Rubbing alcohol and tried my best not to scratch.  It is unknown if patient physician provided consent to be contacted. It is unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  Corrective treatment: applied ice and rubbing alcohol.  At the time of reporting, the outcome of event was reported as unknown.  There will be no information available on the batch number for this case.
A day after shots my arm locked up and unable to use it, lift it. Its horrible pain and locks up at certain positions. Already a month gone by and I can move it a little more, not much. Went to chiropractor and got 2 electric stimulation sessions/
Administered expired vaccine 6 months and up vaccine that expired June 18, 2023; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine 6 months and up vaccine that expired June 18, 2023) and NO ADVERSE EVENT (No adverse event) in a 34-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 069H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine 6 months and up vaccine that expired June 18, 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine 6 months and up vaccine that expired June 18, 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine 6 months and up vaccine that expired June 18, 2023).    No concomitant medication was reported.  No treatment information was reported.
Soreness in her arm; Itchiness going down to her elbow; Redness going down to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in her arm), PRURITUS (Itchiness going down to her elbow) and ERYTHEMA (Redness going down to her elbow) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045c21a, 026l20a and 038l20a) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Sep-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm), PRURITUS (Itchiness going down to her elbow) and ERYTHEMA (Redness going down to her elbow). At the time of the report, PAIN IN EXTREMITY (Soreness in her arm), PRURITUS (Itchiness going down to her elbow) and ERYTHEMA (Redness going down to her elbow) had not resolved.            No concomitant medication reported. No treatment medication reported.  Patient stated she didn't experience any similar reaction with the 1st and 2nd dose.
Information has been received from a physician (also reported as an office manager) concerning a 62 year old female patient with no pertinent medical history who on 19-JUN-2008 was vaccinated with a 0.65ml single dose of ZOSTAVAX (Merck). There was no concomitant medication. On 18-JAN-2010 the patient experienced severe pain and terrible rash in her rectal area. The rash was around her right buttocks. It was painful and couldn't move. The patient went to the doctor's office for medical attention. No laboratory diagnostic studies were ferformed. The patient was prescribed  ZOVIRAX, ULTRAM and advised on some symptomatic treatment (manufacturers unspecified) and the patient came back the next day and stated that nothing helped. THe patient was then prescribed other medication including NEURONTIN and ketorolac tromethamine. The patient had not come back for follow-up since then. At the time of the report, the patient had not recovered. The patient's severe pain and terrible rash in rectal area, around right buttocks were considered to be disabling by the reporter. No further information is available.
Sore arm, moderate body aches, fatigue, mild headache 14 hrs post 2nd vaccine First vaccine zero side effects except arm soreness
I experienced Shingles on my head and the nerve system that goes around my right eye. My eyebrow area had bumps around it. It was itchy and I started scratching it. Then it started bleeding. I happened to be traveling at the time. I called my doctor and I received a prescription of Valacyclovir. I took the medication for a week. I had minor pain for the first three days. I also saw my ophthalmologist on March 27, 2023.
Pt. received VZV vaccine #1 on 12/17/18 - offered no complaints and stated he felt fine. On 12/31/18 pt noticed a rash starting under (R) arm, additional spots on (L) groin, back of neck, top of (R) foot, (R) abdominal area and (L) arm near antecubital area. No C/O fever 98.4 and 98.5, B/P increased slightly, C/O itching.